4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-17-051984
Director disposed of 2,614,157 shares (other)
- Director acquired 366,499 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2017-09-05 | Other disposition | −1,368,013 | 2,736,032 | I: show line 1 in the form | ||
| Bolzon Bradley J PhD Director | 2017-09-05 | Other disposition | −8,110 | 16,224 | I: show line 2 in the form | ||
| Bolzon Bradley J PhD Director | 2017-09-05 | Other disposition | −814,599 | 1,629,204 | I: show line 3 in the form | ||
| Bolzon Bradley J PhD Director | 2017-09-05 | Other disposition | −23,899 | 47,801 | I: show line 4 in the form | ||
| Bolzon Bradley J PhD Director | 2017-09-05 | Other disposition | −61,993 | 123,994 | I: show line 5 in the form | ||
| Bolzon Bradley J PhD Director | 2017-09-05 | Other disposition | −26,491 | 52,987 | I: show line 6 in the form | ||
| Bolzon Bradley J PhD Director | 2017-09-05 | Other acquisition | +292,529 | 292,529 | I: show line 7 in the form | ||
| Bolzon Bradley J PhD Director | 2017-09-05 | Other disposition | −292,529 | 0 | I: show line 8 in the form |
Loading xslF345X03/doc4.xml…